- Poster presentation
- Open Access
Successful treatment with two siblings affected classic Bartter syndrome
© Khanh and Dung; licensee BioMed Central Ltd. 2015
Published: 28 April 2015
Classic Bartter syndrome is a salt-wasting tubulopathy caused by mutations in the CLCNKB (chloride channel Kb) gene. Classic Bartter syndrome is characterized by early childhood onset. Herein, we report two Vietnamese siblings affected classic Bartter syndrome.
Two siblings were admitted to National Hospital of Pediatrics with chief complaints of motor-development delay, growth retardation and failure of thrive. The 1st child - a 39 month old boy with his birth weight of 1.9 kg presented with his height of 69 cm (-7.5 SD), his weight of 7.5 kg (-4.4 SD). The 2nd child – an 18 months old girl presented with her height of 58 cm (-7.8 SD), her weight of 5.8 kg (-3.4 SD). They both developed polyuria (6ml/kg/hour), polydipsia, chronic dehydration and motor delay that they could not stand and walk but had normal intelligence. The investigations revealed hypokalemic metabolic alkalosis (PH: 7.5 – 7.51; pCO2: 45.9 - 56.8 mmHg; HCO3-: 36.6 - 45.7 mmol/l; serum potassium levels: 1.8 – 2.1 mmol/l), hyponatremia (125 – 128 mmol/l), hypochloremia (67 – 84 mmol/l), normal calcemia, and normal calciuria. They were treated with potassium supplement, indomethacin (2.5 mg/kg/day). After 15 months of treatment: height, weight of the 1st boy and 2nd girl were 94 cm (increasing 25cm; -3 SD), 12kg (increasing 4.5kg; -3 SD) and 84 cm (increasing 26 cm; -2.4 SD), 11 kg (increasing 5.2 kg; -1.3 SD), respectively. Their plasma electrolyte became normal after 2 weeks of treatment.
Classic Bartter syndrome will have good prognosis if treated early. This is one cause that can result in growth retardation.
Written informed consent was obtained from the patient for publication of this Case report (and any accompanying images). A copy of the written consent is available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.